Your browser doesn't support javascript.
loading
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance.
Fronik, Philipp; Gutmann, Michael; Vician, Petra; Stojanovic, Mirjana; Kastner, Alexander; Heffeter, Petra; Pirker, Christine; Keppler, Bernhard K; Berger, Walter; Kowol, Christian R.
Afiliação
  • Fronik P; University of Vienna, Faculty of Chemistry, Institute of Inorganic Chemistry, Waehringer Strasse 42, 1090, Vienna, Austria.
  • Gutmann M; Center of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
  • Vician P; Research Cluster "Translational Cancer Therapy Research", 1090, Vienna, Austria.
  • Stojanovic M; Center of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
  • Kastner A; Center of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
  • Heffeter P; University of Vienna, Faculty of Chemistry, Institute of Inorganic Chemistry, Waehringer Strasse 42, 1090, Vienna, Austria.
  • Pirker C; Center of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
  • Keppler BK; Research Cluster "Translational Cancer Therapy Research", 1090, Vienna, Austria.
  • Berger W; Center of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria.
  • Kowol CR; Research Cluster "Translational Cancer Therapy Research", 1090, Vienna, Austria.
Commun Chem ; 5(1): 46, 2022 Apr 06.
Article em En | MEDLINE | ID: mdl-36697790

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Commun Chem Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Commun Chem Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria